What is ResMed's investments - amortized cost basis?

ResMed (RMD) reported investments - amortized cost basis of $78.47M in Q1 2026.

How has ResMed's investments - amortized cost basis changed year-over-year?

ResMed's investments - amortized cost basis increased by 20.0% year-over-year, from $65.38M to $78.47M.

What is the long-term trend for ResMed's investments - amortized cost basis?

Over 4 years (2021 to 2025), ResMed's investments - amortized cost basis has grown at a 29.0% compound annual growth rate (CAGR), from $23.00M to $63.64M.

Discontinued — last reported Q1 '16

Non-Current Assets

Investments - Amortized Cost Basis

ResMed Investments - Amortized Cost Basis increased by 21.1% to $78.47M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.0%, from $65.38M to $78.47M. Over 4 years (FY 2021 to FY 2025), Investments - Amortized Cost Basis shows an upward trend with a 29.0% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

First reportedQ2 2015

Last reportedQ1 2016

Metric ID: investments_amortized_cost

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$23.00M	$31.16M	$35.18M	$38.18M	$39.29M	$43.58M	$65.70M	$70.64M	$68.75M	$69.68M	$74.99M	$77.38M	$73.74M	$65.78M	$66.46M	$65.38M	$63.64M	$64.53M	$64.78M	$78.47M
QoQ Change	—	+35.5%	+12.9%	+8.5%	+2.9%	+10.9%	+50.7%	+7.5%	-2.7%	+1.4%	+7.6%	+3.2%	-4.7%	-10.8%	+1.0%	-1.6%	-2.7%	+1.4%	+0.4%	+21.1%
YoY Change	—	—	—	—	+70.8%	+39.9%	+86.7%	+85.0%	+75.0%	+59.9%	+14.1%	+9.5%	+7.3%	-5.6%	-11.4%	-15.5%	-13.7%	-1.9%	-2.5%	+20.0%

Range$23.00M – $78.47M

CAGR+29.5%

Avg YoY Growth+26.1%

Median YoY Growth+11.8%

Current Streak3 quarters growth

Frequently Asked Questions

What is ResMed's investments - amortized cost basis?: ResMed (RMD) reported investments - amortized cost basis of $78.47M in Q1 2026.
How has ResMed's investments - amortized cost basis changed year-over-year?: ResMed's investments - amortized cost basis increased by 20.0% year-over-year, from $65.38M to $78.47M.
What is the long-term trend for ResMed's investments - amortized cost basis?: Over 4 years (2021 to 2025), ResMed's investments - amortized cost basis has grown at a 29.0% compound annual growth rate (CAGR), from $23.00M to $63.64M.